|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...28293031323334353637383940» |
- modafinil / Generic mfg.
Enrollment change: Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals (clinicaltrials.gov) - Mar 1, 2012
P2, N=73, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=200 --> 73
- modafinil / Generic mfg.
Trial completion: Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals (clinicaltrials.gov) - Mar 1, 2012
P2, N=73, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=200 --> 73 Recruiting --> Completed
- Enrollment change: NIKOGEN: Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail (clinicaltrials.gov) - Feb 29, 2012
P1/2, N=101, Completed, Sponsor: Heinrich-Heine University, Duesseldorf
Recruiting --> Completed N=200 --> 101
- aripiprazole / Generic mfg.
Enrollment change: Aripiprazole to Reduce Cocaine Relapse (clinicaltrials.gov) - Feb 29, 2012
P1, N=41, Completed, Sponsor: University of Kentucky
N=200 --> 101 N=32 --> 41
- carbidopa/levodopa / Generic mfg.
Trial completion: Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence (clinicaltrials.gov) - Feb 29, 2012
P2, N=160, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=32 --> 41 Recruiting --> Completed
- Trial completion: NIKOGEN: Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail (clinicaltrials.gov) - Feb 29, 2012
P1/2, N=101, Completed, Sponsor: Heinrich-Heine University, Duesseldorf
Recruiting --> Completed Active, not recruiting --> Completed
- aripiprazole / Generic mfg.
Trial completion: Aripiprazole to Reduce Cocaine Relapse (clinicaltrials.gov) - Feb 29, 2012
P1, N=41, Completed, Sponsor: University of Kentucky
Active, not recruiting --> Completed Recruiting --> Completed
- atomoxetine / Generic mfg., dextroamphetamine immediate release / Generic mfg.
Enrollment change: Agonist Replacement Therapy for Cocaine Dependence (clinicaltrials.gov) - Feb 28, 2012
P1, N=46, Completed, Sponsor: University of Kentucky
Recruiting --> Completed N=64 --> 46
- atomoxetine / Generic mfg., dextroamphetamine immediate release / Generic mfg.
Trial completion: Agonist Replacement Therapy for Cocaine Dependence (clinicaltrials.gov) - Feb 28, 2012
P1, N=46, Completed, Sponsor: University of Kentucky
N=64 --> 46 Recruiting --> Completed
- | Akineton (biperiden) / Endo, AbbVie
Trial completion: Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients (clinicaltrials.gov) - Feb 28, 2012
P2/3, N=85, Completed, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting --> Completed Recruiting --> Completed
- | New P4 trial: Neuropsychological Prognosis Factors of Smoking Cessation (clinicaltrials.gov) - Feb 23, 2012
P4, N=135, Active, not recruiting, Sponsor: University Hospital, Montpellier
- | New P2 trial: ProjectSTART: Screening to Augment Referral to Treatment- Project START (clinicaltrials.gov) - Feb 23, 2012
P2, N=660, Recruiting, Sponsor: Yale University
- Enrollment open: Integrated Treatment for Smoking Cessation & Anxiety in People With HIV (clinicaltrials.gov) - Feb 23, 2012
P1, N=12, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- acetylcysteine solution / Generic mfg.
Enrollment closed: N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers (clinicaltrials.gov) - Feb 22, 2012
P2, N=80, Active, not recruiting, Sponsor: Yale University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: Contingency Management in the Delivery of HAART to Drug Users in Chennai, India (clinicaltrials.gov) - Feb 21, 2012
P2, N=120, Completed, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Campral EC (acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Trial termination: Study of Acamprosate in Driving Under the Influence (DUI) Court Participants (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=4, Terminated, Sponsor: University of Oklahoma
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Recruitment barriers.
- | methadone / Generic mfg.
Trial initiation date: Methaville: Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices (clinicaltrials.gov) - Feb 20, 2012
P3, N=197, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Active, not recruiting --> Terminated; Recruitment barriers. Initiation date: Sep 2008 --> Jan 2009
- | methadone / Generic mfg.
Enrollment change: Methaville: Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices (clinicaltrials.gov) - Feb 20, 2012
P3, N=197, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Initiation date: Sep 2008 --> Jan 2009 N=300 --> 197
- dextroamphetamine extended release capsule / Generic mfg.
Enrollment change: Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Feb 20, 2012
P2, N=5, Terminated, Sponsor: The University of Texas Health Science Center, Houston
N=300 --> 197 N=40 --> 5
- Campral EC (acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Enrollment change: Study of Acamprosate in Driving Under the Influence (DUI) Court Participants (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=4, Terminated, Sponsor: University of Oklahoma
N=40 --> 5 N=30 --> 4
- | methadone / Generic mfg.
Trial completion: Methaville: Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices (clinicaltrials.gov) - Feb 20, 2012
P3, N=197, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=30 --> 4 Not yet recruiting --> Completed
- ondansetron / Generic mfg., sertraline / Generic mfg.
Enrollment change: Matching Genotypes and Serotonergic Medications for Alcoholism (clinicaltrials.gov) - Feb 17, 2012
P1, N=79, Completed, Sponsor: Brown University
Not yet recruiting --> Completed N=132 --> 79
- ondansetron / Generic mfg., sertraline / Generic mfg.
Trial completion: Matching Genotypes and Serotonergic Medications for Alcoholism (clinicaltrials.gov) - Feb 17, 2012
P1, N=79, Completed, Sponsor: Brown University
N=132 --> 79 Recruiting --> Completed
- | New P1/2 trial: The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence (clinicaltrials.gov) - Feb 16, 2012
P1/2, N=60, Recruiting, Sponsor: New York State Psychiatric Institute
- oxycodone/naloxone ER / Generic mfg.
Trial completion, Surgery: A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery (clinicaltrials.gov) - Feb 16, 2012
P4, N=165, Completed, Sponsor: Kati J
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Tobacco Zero: Interactive Tobacco Education for Teens (clinicaltrials.gov) - Feb 15, 2012
P2, N=1864, Completed, Sponsor: Deschutes Research, Inc.
Recruiting --> Completed Not yet recruiting --> Completed
- Lucemyra (lofexidine) / US WorldMeds, Stada
New P1 trial: Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients (clinicaltrials.gov) - Feb 13, 2012
P1, N=6, Completed, Sponsor: US WorldMeds LLC
- disulfiram / Generic mfg.
Trial completion: Disulfiram for Cocaine Abuse (clinicaltrials.gov) - Feb 6, 2012
P2, N=118, Completed, Sponsor: University of Arkansas
Not yet recruiting --> Completed Recruiting --> Completed
- bavisant (JNJ-31001074) / J&J, BenevolentAI
Trial withdrawal: Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults (clinicaltrials.gov) - Feb 5, 2012
P2, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed Not yet recruiting --> Withdrawn
- naltrexone / Generic mfg., topiramate / Generic mfg.
Enrollment change: Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study (clinicaltrials.gov) - Feb 2, 2012
P1, N=4, Completed, Sponsor: Bankole Johnson
Not yet recruiting --> Withdrawn N=30 --> 4
- topiramate / Generic mfg.
Enrollment change: New Medications to Treat Alcohol Dependence (clinicaltrials.gov) - Feb 2, 2012
P2, N=29, Completed, Sponsor: Bankole Johnson
N=30 --> 4 N=134 --> 29
- topiramate / Generic mfg.
Enrollment change: Topiramate to Reduce Cocaine Dependence (clinicaltrials.gov) - Feb 2, 2012
P2, N=25, Completed, Sponsor: Bankole Johnson
N=134 --> 29 N=40 --> 25
- | New P2 trial: Improving Learning-based Treatment of Cocaine Dependence With Medication (clinicaltrials.gov) - Feb 2, 2012
P2, N=135, Completed, Sponsor: Johns Hopkins University
- Enrollment closed, Metastases: Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (clinicaltrials.gov) - Feb 2, 2012
P1, N=10, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
N=40 --> 25 Recruiting --> Active, not recruiting
- naltrexone / Generic mfg., topiramate / Generic mfg.
Trial completion: Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study (clinicaltrials.gov) - Feb 2, 2012
P1, N=4, Completed, Sponsor: Bankole Johnson
Recruiting --> Active, not recruiting Recruiting --> Completed
- | ondansetron / Generic mfg.
Trial completion: Pharmacological Treatment for Alcoholism (clinicaltrials.gov) - Feb 2, 2012
P3, N=283, Completed, Sponsor: Bankole Johnson
Recruiting --> Completed Active, not recruiting --> Completed
- topiramate / Generic mfg.
Trial completion: Topiramate to Reduce Cocaine Dependence (clinicaltrials.gov) - Feb 2, 2012
P2, N=25, Completed, Sponsor: Bankole Johnson
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders (clinicaltrials.gov) - Jan 31, 2012
P=N/A, N=76, Completed, Sponsor: University of Oslo
Recruiting --> Completed N=150 --> 76
- Trial completion: Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders (clinicaltrials.gov) - Jan 31, 2012
P=N/A, N=76, Completed, Sponsor: University of Oslo
N=150 --> 76 Recruiting --> Completed
- Trial completion: TSFDD: 12-step Facilitation for the Dually Diagnosed (clinicaltrials.gov) - Jan 30, 2012
P1/2, N=121, Completed, Sponsor: University of New Mexico
Recruiting --> Completed Active, not recruiting --> Completed
- topiramate / Generic mfg.
Trial withdrawal: Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence (clinicaltrials.gov) - Jan 25, 2012
P3, N=0, Withdrawn, Sponsor: Elizabeth Ralevski
Active, not recruiting --> Completed Recruiting --> Withdrawn
- topiramate / Generic mfg.
Enrollment change: Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence (clinicaltrials.gov) - Jan 25, 2012
P3, N=0, Withdrawn, Sponsor: Elizabeth Ralevski
Recruiting --> Withdrawn N=30 --> 0
- Enrollment closed: Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism (clinicaltrials.gov) - Jan 25, 2012
P2, N=46, Active, not recruiting, Sponsor: Elizabeth Ralevski
N=30 --> 0 Recruiting --> Active, not recruiting
- | Trial completion: Rapid HIV Testing and Counseling in Drug Abuse Treatment (clinicaltrials.gov) - Jan 25, 2012
P3, N=1281, Completed, Sponsor: University of Miami
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
New P1 trial: Pioglitazone to Treat Opioid Withdrawal Symptoms (clinicaltrials.gov) - Jan 23, 2012
P1, N=120, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
- ||| Trial completion: Overcoming Psychiatric Barriers to the Treatment of Hepatitis C (clinicaltrials.gov) - Jan 23, 2012
P=N/A, N=101, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date: iQS: A Randomized Trial of Internet Access to Nicotine Patches (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=2475, Active, not recruiting, Sponsor: University of Michigan
Active, not recruiting --> Completed Initiation date: Oct 2009 --> Mar 2011
- Enrollment change: Patient Feedback Effectiveness Study (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=118, Completed, Sponsor: University of Pennsylvania
Initiation date: Oct 2009 --> Mar 2011 N=250 --> 118
- Trial completion: Patient Feedback Effectiveness Study (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=118, Completed, Sponsor: University of Pennsylvania
N=250 --> 118 Active, not recruiting --> Completed
- | New P1 trial: A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers (clinicaltrials.gov) - Jan 17, 2012
P1, N=35, Completed, Sponsor: Pfizer